Sword Bio Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

Sword Bio General Information

Description

Developer of medical data research platform designed to determine and monitor the value of biological markers. The company's platform uses a patented technology involving resonance Raman to enhance the performance of the assays, enabling scientists to get more robust and reliable data and continue advances in medical research, drug discovery, and the provision of healthcare products and services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 13295 Illinois Street
  • Suite 103
  • Carmel, IN 46032
  • United States
+1 (866)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 13295 Illinois Street
  • Suite 103
  • Carmel, IN 46032
  • United States
+1 (866)

Sword Bio Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sword Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator Completed Generating Revenue
6. Later Stage VC 26-Jun-2023 Completed Generating Revenue
5. Secondary Transaction - Private 01-Mar-2022 Completed Generating Revenue
4. Later Stage VC (Series B1) 26-Mar-2018 Completed Generating Revenue
3. Early Stage VC (Series B) 21-Nov-2008 Completed Generating Revenue
2. Early Stage VC 31-Mar-2005 $500K $3M Completed Startup
1. Early Stage VC (Series B) 08-Mar-2004 $2.5M $2.5M Completed Startup
To view Sword Bio’s complete valuation and funding history, request access »

Sword Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A-1 3,499,020 $0.001000 $0.01 $0.14 $0.14 1x $0.14 13.81%
To view Sword Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sword Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical data research platform designed to determine and monitor the value of biological markers. The compa
Biotechnology
Carmel, IN
23 As of 2024

Cologne, Germany
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sword Bio Competitors (21)

One of Sword Bio’s 21 competitors is Ayoxxa Biosystems, a Formerly VC-backed company based in Cologne, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ayoxxa Biosystems Formerly VC-backed Cologne, Germany
OpGen Formerly VC-backed Rockville, MD
RayBiotech Venture Capital-Backed Peachtree Corners, GA
Avitide Formerly VC-backed Lebanon, NH
Novus Biologicals Formerly PE-Backed Centennial, CO
You’re viewing 5 of 21 competitors. Get the full list »

Sword Bio Patents

Sword Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2553117-A1 Methods for detecting raman scattering using aromatic compounds comprising phosphate and at least one non-laser light source Inactive 28-Mar-2010
CA-2794130-A1 Methods for detecting raman scattering using aromatic compounds comprising phosphate and at least one non-laser light source Active 28-Mar-2010
CA-2794130-C Methods for detecting raman scattering using aromatic compounds comprising phosphate and at least one non-laser light source Active 28-Mar-2010
CA-2751756-A1 Methods for detecting organisms and enzymatic reactions using raman spectroscopy and aromatic compounds comprising phosphate Active 17-Feb-2009
EP-2398910-A1 Methods for detecting organisms and enzymatic reactions using raman spectroscopy and aromatic compounds comprising phosphate Inactive 17-Feb-2009 C12Q1/28
To view Sword Bio’s complete patent history, request access »

Sword Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sword Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Elevate Ventures Venture Capital Minority
Heartland Angels Angel Group Minority
Jumpstart NJ Angel Network Angel Group Minority
Keiretsu Forum Venture Capital Minority
Tech Council Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Sword Bio FAQs

  • When was Sword Bio founded?

    Sword Bio was founded in 2004.

  • Where is Sword Bio headquartered?

    Sword Bio is headquartered in Carmel, IN.

  • What is the size of Sword Bio?

    Sword Bio has 23 total employees.

  • What industry is Sword Bio in?

    Sword Bio’s primary industry is Biotechnology.

  • Is Sword Bio a private or public company?

    Sword Bio is a Private company.

  • What is Sword Bio’s current revenue?

    The current revenue for Sword Bio is .

  • How much funding has Sword Bio raised over time?

    Sword Bio has raised $10.2M.

  • Who are Sword Bio’s investors?

    Elevate Ventures, Heartland Angels, Jumpstart NJ Angel Network, Keiretsu Forum, and Tech Council Ventures are 5 of 7 investors who have invested in Sword Bio.

  • Who are Sword Bio’s competitors?

    Ayoxxa Biosystems, OpGen, RayBiotech, Avitide, and Novus Biologicals are some of the 21 competitors of Sword Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »